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SUMMARY
In Neospora caninum and Toxoplasma gondii, the parasitophorous vacuole (PV) is synthesized at the time of infection.
During tachyzoite-to-bradyzoite stage conversion, the PV is later transformed into a tissue cyst that allows parasites to
survive in their host for extended periods of time. We report on the characterization of NcMAG1, the N. caninum
orthologue of T. gondii MAG1 (matrix antigen 1; TgMAG1). The 456 amino acid predicted NcMAG1 protein is 54%
identical to TgMAG1. By immunoblotting, a rabbit antiserum raised against recombinant NcMAG1 detected a major
product of y67 kDa in extracts of N. caninum tachyzoite-infected Vero cells, which was stained more prominently in
extracts of infected Vero cells treated to induce in vitro bradyzoite conversion. Immunoﬂuorescence andTEM localized the
protein mainly within the cyst wall and the cyst matrix. In both tachyzoites and bradyzoites, NcMAG1 was associated
with the parasite dense granules. Comparison between NcMAG1 and TgMAG1 amino acid sequences revealed that
the C-terminal conserved regions exhibit 66% identity, while the N-terminal variable regions exhibit only 32%
identity. Antibodies against NcMAG1-conserved region cross-reacted with the orthologuous protein in T. gondii
but those against the variable region did not. This indicates that the variable region possesses unique antigenic charac-
teristics.
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INTRODUCTION
Neospora caninum is an intracellular apicomplexan
parasite that is closely related to Toxoplasma gondii,
and represents a major cause of abortion in cattle and
neuromuscular disease in dogs worldwide (Dubey
et al. 2006; Hemphill et al. 2006). Transplacental
transmission is regarded as the major source of in-
fection. The life cycle of N. caninum consists of
3 principal stages: (1) tachyzoites, which rapidly
replicate within the parasitophorous vacuole (PV),
and disseminate in the host during the acute phase,
(2) bradyzoites, slowly dividing parasites, which are
enclosed within a tissue cyst that develops particu-
larly in the brain during the chronic phase of the
infection (Dubey et al. 2006), and (3) oocysts which
represent the product of a sexual process taking place
within the intestine of the deﬁnitive hosts (dog and
coyote), and upon fecal shedding, sporulate and form
sporozoites (McAllister et al. 1998; Gondim et al.
2004). There is evidence that tachyzoites diﬀerentiate
into bradyzoites as a reaction to the immune response
occurring in immune-competent hosts (Dubey et al.
2006; Hemphill et al. 2006).
Intracellularly, all invasive stages of N. caninum
are located within a parasitophorous vacuole (PV),
separated from the host cell cytoplasm through the
parasitophorous vacuole membrane (PVM). The
PVM is derived from the host cell cytoplasmic
membrane during host cell invasion, and sub-
sequently undergoes important modiﬁcations. While
proteins secreted by the parasite are incorporated
into the PVM, those of the host cell are selectively
eliminated and the PV becomes resistant to fusion
with lysosomes (Beyer et al. 2002). The PV of
T. gondii transforms into a tissue cyst very early after
parasite penetration into brain cells, and the PVM
progressively matures into a cyst wall that protects
bradyzoites from the immunological and physio-
logical responses on part of the host (Beyer et al.,
2002). Intact tissue cysts containing bradyzoites of
both N. caninum and T. gondii can persist in the
host, usually without being harmful or causing an
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inﬂammatory response (Dubey et al. 1988; Innes
et al. 2002).
The proteins involved in tachyzoite-bradyzoite
interconversion could represent important targets
for vaccination or chemotherapy in order to prevent
or reduce the development of intra-cerebral cysts.
Stage-speciﬁcally expressed proteins inT. gondii and
N. caninum have been identiﬁed (McAllister et al.
1996; Fuchs et al. 1998; Ferguson, 2004; Risco-
Castillo et al. 2007; Aguado-Martinez et al. 2009),
while others are expressed in both stages, but diﬀer
in their localization (Vonlaufen et al. 2004). In this
context, T. gondii MAG1 was ﬁrst reported as
a bradyzoite-speciﬁc antigen localized in the cyst
matrix (Parmley et al. 1994). Subsequently, the
protein was also detected in the parasitophorous
vacuoles containing intracellular tachyzoites and in
tachyzoite lysates (Ferguson and Parmley, 2002).
Besides its importance as a marker for cerebral in-
fection withT. gondii in AIDS patients (Contini et al.
2002; Pfrepper et al. 2005), TgMAG1 represents a
potentially useful tool for the immunodiagnosis of
patients with toxoplasmosis (Di Cristina et al. 2004;
Pfrepper et al. 2005). In addition, TgMAG1 has
been considered as a promising candidate in vacci-
nation trials (Parmley et al. 2002; Nielsen et al.
2006). We have recently shown that intraperitoneal
vaccination of mice with recombinant NcMAG1
expressed in E. coli confers 50% protection against
experimentalN. caninum infection in a murine acute
diseasemodel (Debache et al. 2009). In this study, we
report on the molecular characterization, localization
and antigenic properties of NcMAG1.
MATERIALS AND METHODS
Parasite cultures
Parasites were cultured as previously described
(Barber et al. 1995; Hemphill and Gottstein, 1996).
Brieﬂy, N. caninum NC-Liverpool or T. gondii
ME49 tachyzoites were maintained in Vero cells
at 37 xC under 5% CO2 in RPMI 1640 medium
containing 10% FCS (Gibco-Invitrogen, Carlsbad,
CA, USA), 2 mM L-glutamine, 50 IU/ml penicillin,
and 50 mg/ml streptomycin. N. caninum grown in
keratinocytes were cultured as previously described
(Vonlaufen et al. 2002).
Tachyzoite-to-bradyzoite stage conversion was
performed in vitro by 10 days treatment of NC-
Liverpool-infected Vero cells with 17 mM sodium
nitroprusside (SNP; Sigma, St Louis, MO, USA),
using a procedure adapted from Vonlaufen et al.
(2004) and by 4 days treatment of T. gondii-infected
Vero cells with 100 mM SNP as previously described
(Bohne et al. 1994; Weiss et al. 1998).
For puriﬁcation, parasites were mechanically re-
leased from infected cells by passing through a 25G,
5/8 needle, washed in ice-cold medium, and run on
PD-10 columns (GE Healthcare, Piscataway, NJ,
USA) as described by Hemphill et al. (1996).
Oligonucleotides
N. caninum MAG1-speciﬁc primers were designed
based on the ApiDots (http://www.cbil.upenn.edu/
apidots/ ; (Li et al. 2003, 2004)) DT.92484705 tran-
script. All primers were purchased from MWG
(Ebersberg, Germany).
RNA isolation and ﬁrst strand cDNA synthesis
Total RNA was isolated from 3r106 puriﬁed
N. caninum Liverpool tachyzoites using Trizol re-
agent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. First strand cDNA
synthesis reactions were performed for 1 h at 42 xC in
a 20 ml reaction mixture containing 2 mg of total
RNA, 1r ﬁrst-strand buﬀer (Invitrogen), 0.5 mM of
each dNTP (Endotell, Allschwil, Switzerland),
10 mM dithiothreitol, 20 U of RNasin RNase in-
hibitor (Promega, Madison, WI, USA), 200 U of
SuperScript II reverse transcriptase (Invitrogen).
Primers (20 pmol) were either MAG1-R1, 5k-CT-
GTCCCTTACACCTACACT-3k, for the 5k-RACE
(Rapid Ampliﬁcation of cDNA Ends) and to gener-
ate the recombinant NcMAG1 protein, or T-primer
3, 5k-AAGCAGTGGTATCAACGCAGAGTA-
C(T)30 VN-3k (V=A, C or G; N=any nucleotide),
for the 3k-RACE (Matz et al. 1999).
RACE procedures
A manual hot-start PCR (Chou et al. 1992) was used
in order to reduce background ampliﬁcations in both
RACE reactions.
For 5k-RACE, the ﬁrst strand cDNA primed with
MAG1-R1 primer was ultraﬁltrated 3 times against
water on a Microcon YM-100 ﬁlter unit (Millipore,
Billerica, MA, USA). The cDNA in the whole
retentate was dA-tailed for 20 min at 37 xC in 50 ml
of 1r terminal deoxynucleotidyl transferase (TdT)
buﬀer (Roche, Basel, Switzerland) using 25 U of
TdT (Roche) and 0.2 mM dATP (Endotell). The
reaction was terminated by heating at 95 xC for
5 min. Two rounds of ampliﬁcation were performed
to generate the 5k-RACE product. The ﬁrst round
was carried out in a 50 ml reaction volume containing
5 ml (1/10th) of the (dA)-tailed product, 5 pmol of
each T-primer 3 and MAG1-R2 (5k-GCATT-
ACCAACTTCGTCCTC-3k) primers, 0.2 mM of
each dNTP and 2.5 U of Pfu DNA polymerase
(Promega) in the supplied reaction buﬀer. Ten PCR
cycles were performed with an annealing tempera-
ture of 55 xC. The second round of ampliﬁcation was
carried out in 50 ml containing 20 ml of the ﬁrst step
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ampliﬁcation reaction, 15 pmol of Heel-carrier (5k-
CTAATACGACTCACTATAGGGCAAGCAG-
TGGTATCAACGCAGAGT-3k) and MAG1-R2
primers, 0.2 mM of each dNTP, and 2.5 U of Pfu
DNA polymerase (Promega) in the supplied reaction
buﬀer. PCR was performed for 30 cycles with an
annealing temperature of 58 xC.
The 3k-RACE reaction was carried out in a 100 ml
reaction mixture containing 2 ml (1/10th) of the ﬁrst
strand cDNA prepared with T-primer 3, 4 pmol
of Heel-carrier primer, 20 pmol of each MAG1-F
(5k-TGAACAACCCTATGAACAAACAGACGC-
3k), and Heel-speciﬁc (5k-CTAATACGACTCA-
CTATAGGGC-3k) primers, 0.2 mM of each dNTP
and 2.5 U of Pfu DNA polymerase in the supplied
reaction buﬀer. PCR was performed for 35 cycles
with an annealing temperature of 55 xC.
Sequencing and sequence analyses
RACE products were cloned into pCR Blunt II
TOPO (Invitrogen) and sequenced using a primer
walking approach. All expression constructs were
veriﬁed by sequencing of the insert. Sequencing re-
actions were carried out using BigDye v3.1 ﬂuor-
escent dye terminators and run on an ABI PRISM
3100 Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA). Raw sequencing data were as-
sembled and edited with the Staden package
(Bonﬁeld et al. 1995). Sequence data reported in this
paper are available in the GenBank database under
the Accession number EF580924.
Homology searches were done using BLAST
(blastp) program (http://www.ncbi.nlm.nih.gov/
blast/ ; (Altschul et al. 1990)) and the Conserved
Domain Database CD-Search (http://www.ncbi.
nlm.nih.gov/Structure/cdd/wrpsb.cgi) with default
settings. Proteins were aligned on the Muscle server
(http://www.drive5.com/muscle/ (Edgar, 2004)),
minimally edited, and formatted with GeneDoc
(Nicholas et al. 1997). Residue grouping and shading
was according to the MM5 reduced amino acid
alphabet ofMelo andMarti-Renom (2006). Potential
signal peptide cleavage sites were identiﬁed
with SignalP 3.0 (http://www.cbs.dtu.dk/services/
SignalP/ (Bendtsen et al. 2004)) and potential trans-
membrane regions were checked with the ProtScale
tool on the Expasy server (http://expasy.org/tools/
protscale.html).
Expression of recombinant N. caninum MAG1
proteins
A portion of NcMAG1, thereafter referred to as
recNcMAG1, encoding aa 31-394 (numbering ac-
cording to the precursor) was ampliﬁed by RT-PCR
using MAG1-BamHI-F (5k-GGATCCCAAAGG-
GTGCCTCGCTACCC-3k) and MAG1-SmaI-R
(5k-CCCGGGTTATTCCTCCACTATTTCGT-
CCGC-3k) primers; BamHI and SmaI restriction
sites underlined. The PCR product was cloned into
pCR blunt II TOPO (Invitrogen) and veriﬁed by
sequencing. The BamHI/SmaI MAG1 insert was
then subcloned into the (His)6-tag pQE-30 ex-
pression vector (Qiagen, Hilden, Germany), result-
ing in pQE-30-NcMAG1. We also expressed
portions of the conserved (C) and variable (V) re-
gions within NcMAG1 (Fig. 2). In order to monitor
their expression and to facilitate their puriﬁcation,
the twoNcMAG1C and V regions were expressed as
(His)6-GFP (green ﬂuorescent protein) fusion pro-
teins in E. coli. The portion of NcMAG1 central to
the C region (aa 241–386, numbering according to
the precursor) was ampliﬁed usingMAG1-C-XmaI-
F (5k-CTGCGTCCCGGGGGACCGACGGTT-
TCGACTCG-3k) and MAG1-C-PstI-R (5k-CT-
GCGTCTGCAGGGTCCCCACGAATTGTCT-
CG-3k) primers; XmaI and PstI restriction sites
underlined. The portion of NcMAG1 central to the
V region (aa 31–162) was ampliﬁed using MAG1-V-
XmaI-F (5k-CTGCGTCCCGGGCAAAGGGT-
GCCTCGCTACCC-3k) and MAG1-V-PstI-R
(5k-CTGC GTCTGCAGCGACGTGGAAAGT-
GGTAGCG-3k) primers; XmaI and PstI restric-
tion sites underlined. The pQE-30-NcMAG1 vector
was used as template for PCR ampliﬁcations. Re-
stricted PCR products were inserted into the XmaI/
PstI-cut pQE-GFP vector (C.G. and F.A., un-
published; sequence available upon request),
resulting in pQE-GFP-MAG1-C and pQE-GFP-
MAG1-V.
Expression vectors were used to transform E. coli
BL21 (Novagen-EMD Biosciences, Madison, WI)
harbouring the pREP4 repressor plasmid (Qiagen).
To express the recombinant proteins, 1 l of 2r YT
medium (per litre : 16 g bacto tryptone, 10 g bacto
yeast extract, and 5 g NaCl), pre-warmed to 37 xC
and supplemented with carbenicillin and kanamycin
(Sigma; 100 and 25 mg/ml, respectively), was in-
oculated with 10 ml of an overnight starter culture
grown in the same medium. When cultures reached
an OD of 0.5 at l=600 nm, isopropyl b-D-1-
thiogalactopyranoside (Sigma) was added to 1 mM
and expression was carried on for 3 h at 37 xC.
Soluble recNcMAG1 and GFP-MAG1-V proteins
were puriﬁed by nickel chelate chromatography on
Protino Ni-IDA columns (Macherey-Nagel, Du¨ren,
Germany), as recommended by the manufacturer.
Due to its extreme sensitivity to proteolysis
after bacterial lysis, GFP-MAG1-C could not
be puriﬁed by chromatography. It was therefore
run on a large format SDS-PAGE gel after boiling
over-expressing bacteria in SDS sample buﬀer.
The whole gel was transferred onto a nitrocellulose
membrane and the major band was excised and
used for the puriﬁcation of anti-GFP-MAG1-C
antibodies.
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Production and puriﬁcation of antibodies
Antisera were obtained after immunization of
2 female white New Zealand rabbits, with 150 mg
of recNcMAG1 antigen per injection, using a stan-
dard 10-week immunization protocol (Institut fu¨r
Labortierkunde, Zurich, Switzerland). Antibodies
speciﬁc to either the whole recNcMAG1, the C or the
V region were aﬃnity-puriﬁed using recNcMAG1,
GFP-MAG1-C or GFP-MAG1-V bound to nitro-
cellulose membranes, respectively (Robinson et al.
1988).
Preparation of protein extracts
For preparation of total protein extracts from in-
fected or uninfected Vero cells, cultures in a T-75
culture ﬂask were washed twice with PBS (137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1
.47 mM
KH2PO4, pH 7
.4) and proteins were extracted with
1 ml of ice-cold RIPA buﬀer (Pierce-Thermo Fisher
Scientiﬁc, Waltham, MA, USA) supplemented with
10 ml/ml Halt protease inhibitor cocktail (Pierce-
Thermo Fisher Scientiﬁc). Protein extracts were
sonicated, clariﬁed by centrifugation, and the protein
concentration in the supernatant was measured using
the DC Protein Assay Kit (Bio-Rad, Hercules, CA,
USA). For SDS-PAGE, samples of protein extracts
from infected cultures were adjusted to contain the
required parasite number using data obtained by
quantitative real-time PCR.
Protein extracts from free parasites were prepared
using 100 ml of RIPA buﬀer per 5r106 puriﬁed
parasites.
Quantitation of parasites
To determine the number of parasites in infected
Vero cells, a quantitative real-time PCR
(LightCycler, Roche Diagnostics, Basel,
Switzerland) was used. DNA was puriﬁed from
Neospora- or Toxoplasma-infected cells using the
High Pure PCR Puriﬁcation kit (Roche Diagnostics)
according to the manufacturer’s recommendations.
DNA concentrations were measured by Hoechst
33258 (Sigma) ﬂuorimetry (Ausubel et al. 1997) on a
Synergy HT plate reader (Biotek Instruments,
Winooski, VT, USA). Experimental procedures
described by Mu¨ller et al. (2002) for Neospora and
Reischl et al. (2003) for Toxoplasma were followed,
using 200 ng DNA per sample. Free parasites were
directly quantiﬁed by counting using a Neubauer
chamber.
SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot
Protein samples were mixed with reducing, de-
naturing sample buﬀer, boiled for 5 min and protein
separation was conducted by SDS-PAGE. Proteins
were transferred onto PVDF membranes (Bio-Rad)
for 1 h at 100 V using a wet transfer apparatus (Bio-
Rad). Membranes were blocked by incubation in a
blocking buﬀer containing 5% non-fat milk in TBST
(20 mM Tris, 150 mM NaCl, 0.1% (v/v) Tween 20)
and then incubated for 2 h at room temperature
or overnight at 4 xC with aﬃnity-puriﬁed anti-
NcMAG1 antibodies at a dilution of 1 : 3000.
Antibodies against the NcMAG1-conserved region
and against the NcMAG1-variable region were ap-
plied at a dilution of 1 : 400. Detection was performed
with a donkey anti-rabbit alkaline phosphatase-
conjugated secondary antibody (Pierce-Thermo
Fisher Scientiﬁc) at a dilution of 1 : 10000 andNBT /
BCIP (nitro blue tetrazolium/bromochloroindolyl
phosphate ; Sigma) (Ausubel et al. 1997).
Immunoﬂuorescence (IF ) analysis
IF staining was performed on puriﬁed parasites or on
parasite-infected Vero cells grown on poly-L lysine-
coated glass cover-slips. For intracellular brady-
zoites, cover-slips were seeded (105 infected cells
per well) on the sixth day following addition of SNP
to the culture medium and the treatment carried
on until day 9 post-infection. Puriﬁed parasites were
ﬁxed using 4% paraformaldehyde in PBS (20 min
at RT). Cover-slips were rinsed 3 times in PBS,
immersed into pre-cooled (x20 xC) methanol/
acetone (v:v), and incubated at x20 xC for 30 min.
The cover-slips were washed 3 times with PBS,
5 min each, and incubated in blocking buﬀer (PBS/
3% BSA) for 2 h. The following primary antibodies,
diluted in PBS/0.3% BSA, were applied: (a) aﬃnity-
puriﬁed polyclonal rabbit anti-NcMAG1 antibody at
a 1 : 2500 dilution, (b) rabbit anti N. caninum anti-
serum (Hemphill et al. 1996) at a 1 : 2500 dilution,
(c) CC2, a rat mAb reacting with aT. gondii cyst wall
antigen (Gross et al. 1995), diluted at 1 : 300, and
(d) rabbit anti-BAG1 polyclonal antibody, directed
against a bradyzoite-speciﬁc antigen (McAllister
et al. 1996), diluted at 1 : 300. Aﬃnity-puriﬁed anti-
bodies against NcMAG1-conserved and NcMAG1-
variable regions were used at 1 : 200 to assess their
cross-reactivity on T. gondii.
Incubations with primary antibodies were per-
formed for 1 h, followed by 3 washes in PBS for
5 min each. Cells were then incubated for 45 min
with the appropriate Alexa Fluor (AF)-labelled sec-
ondary antibodies (Invitrogen) at a dilution of
1 : 3000 (AF-488-, AF-546) or 1 : 300 (AF-350) in
PBS/0.3% BSA. For multiple detection, antibodies
were applied sequentially, without a given order.
Finally, the preparations were washed in PBS 3 times
for 5 min each. Cover-slips with infected cells were
incubated for 2 min in PBS containingDAPI at 1 mg/
ml to stain nuclei, rinsed brieﬂy in PBS, andmounted
in ProLong Gold antifade reagent (Invitrogen).
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Images were acquired on an Axioskop 2 microscope
equippedwith anAxioCamCCDcamera (Carl Zeiss,
Oberkochen, Germany) or on a Nikon Eclipse 80i
microscope (Kanagawa, Japan) equipped with a
QImaging cooled CCD camera (Retiga 2000R Fast
1394; Surrey, BC, Canada). Images were processed
with ImageJ 1.38 software (http://rsb.info.nih.gov/
ij/ ; (Abramoﬀ et al. 2004)).
Immunogold-labelling and transmission electron
microscopy (TEM)
LR-White embedding and on-section labelling of
N. caninum cultures were performed essentially as
previously described (Hemphill and Croft, 1997;
Vonlaufen et al. 2002, 2004). Sections were loaded
onto formvar-carbon coated grids and non-speciﬁc
binding sites were blocked for 2 h in PBS/1%
BSA. They were then incubated in aﬃnity-puriﬁed
anti-NcMAG1 antibodies, diluted 1 : 100 in PBS/
0.1% BSA for 1 h. After washing in 5 changes of
PBS (2 min each), the goat anti-rabbit antibody
conjugated to 10 nm diameter gold particles
(Amersham) was applied at a dilution of 1 : 5 in PBS/
0.1% BSA. After extensive washing in PBS, grids
were air-dried and stained with lead citrate and
uranyl acetate. Specimens were viewed on a Philips
400 TEM (Philips Electronics, Eindhoven, The
Netherlands) operating at 80 kV.
RESULTS
Cloning and analysis of a cDNA encoding
Neospora caninumMAG1
A sequence homology search against N. caninum
expressed sequence tags (ESTs) in the ApiDots
database (Li et al. 2003, 2004) usingT. gondiiMAG1
cDNA (Parmley et al. 1994) resulted in a single hit,
a 2886 NT assembly of 21 ESTs: DT.92484705.
This consensus sequence possesses an open reading
frame (ORF) potentially encoding a protein sharing
over 50% identity with T. gondiiMAG1. To conﬁrm
the DT.92484705 data, we ampliﬁed NcMAG1
cDNA by RACE, using a ﬁrst strand cDNA pre-
pared from N. caninum Liverpool tachyzoites as a
template. The 5k-RACE reaction produced a single
amplicon of y1.5 kb, consistent with the sequence
of the ﬁve 5k-RACE clones that we analysed. On
the contrary, agarose gel electrophoresis of 3k-RACE
products revealed a more complex banding pattern,
with discrete fragments ranging from 0.6 to over
1.5 kb (data not shown). After bulk cloning and
sequencing of twelve 3k-RACE products, we found
that diﬀerences between clones were limited to
their 3k-end, immediately preceding the poly(A)
tail, suggesting an alternative polyadenylation site
usage.
The unique 5k- and the longest 3k-RACE products,
overlapping by 345 NT, were used to build a 2288
NTNcMAG1 cDNA sequence (GenBank Accession
no. EF580924; Fig 1). The consensus cDNA
possesses a 1371 nucleotide ORF (including the
TGA stop codon), potentially encoding a 456 amino
acid protein identical to that predicted to be encoded
by the DT. 92484705 transcript. The putative ATG
initiation codon is part of a sequence (AGCA-
CAATGG) matching 8 positions of the previously
described T. gondii translation initiation consensus
sequence (gNCAAaATGg) (Seeber, 1997). An ad-
ditional, out-of-frame, ATG triplet was found closer
to the NcMAG1 cDNA 5k-end (NT 52–54); how-
ever, in a context apparently less favourable for
translation initiation.
The predicted 5k-UTR is 128 NT long, 76 NT
shorter than in the ApiDots transcript. The twelve
3k-RACE clones sequenced had a 3k-UTR ranging
from 304 to 789 NT and a poly(A) tail, but electro-
phoretic analysis of 3k-RACE products suggested
that polyadenylation of the NcMAG1 transcript
could occur even further downstream, consistent
with the longer 3k-UTRpresent on theDT.92484705
transcript. We did not observe any consensus eu-
karyotic polyadenylation signal (AATAAA) down-
stream of the coding sequence. However, performing
a less stringent search, 6 out of the 12 analysed
transcripts appeared to be terminated in close
vicinity (within the generally accepted 10–30 NT
window) to upstream sequences diﬀering at most by
1 mismatch from the consensus AATAAA hexamer.
An imperfect 84/90 NT direct repeat was identiﬁed
(NT 1934–2017 and 2019–2108) in the 3k-UTR
(Fig. 1).
The predicted NcMAG1 precursor is 54%
identical to TgMAG1 (Fig. 2) but does not share
signiﬁcant similarity to any other protein in
GenBank nor in the Conserved Domain Database
(CDD v2.17, October 2009). A typical signal peptide
with a predicted signal peptidase cleavage site be-
tween Gly30 and Gln31 was identiﬁed by SignalP 3.0
with the hidden Markov models and the neural
networks prediction methods (Bendtsen et al.
2004). The position of the predicted cleavage site
was conserved in TgMAG1, but only with the
hidden Markov models method (Fig. 2). The pre-
dicted MWs of NcMAG1 are 52.9 and 50.5 kDa,
for the precursor and the mature protein, respect-
ively.
We did not identify a hydrophobic region that
could represent an internal transmembrane domain.
The predicted NcMAG1 and TgMAG1 mature
proteins share an overall 53% identity but sequence
conservation is not homogeneously distributed along
the proteins. The C-terminal region (aa189–456) is
much more conserved than the N-terminal region
(aa 31–188), with 66% and 32% sequence identity,
respectively (Fig. 2).
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Expression and immunolocalization of NcMAG1
in N. caninum tachyzoites and bradyzoites
A recombinant protein (recNcMAG1), comprising
aa 31–394, was expressed as a (His)6-tagged fusion
protein in E. coli and used to immunize rabbits. All
intermediate and ﬁnal bleeds had a high titre against
the puriﬁed recombinant protein as determined by
Western blot and ELISA (data not shown). Sera
from the third bleed were aﬃnity-puriﬁed against
recNcMAG1 and used for all further experiments.
In Western blots of protein extracts from puriﬁed
extracellular N. caninum, anti-NcMAG1 antibodies
detected a y67 kDa band. The band was more
prominent in lysates from SNP-treated cultures
(containing predominantly bradyzoites) than in
tachyzoite lysates (Fig. 3, lanes 1 and 2). Similarly,
the protein was much more abundant in lysates of
SNP-treatedNeospora-infected Vero cells compared
to untreated, infected cells (Fig. 3, lanes 3 and 4).
The antibodies did not show any reactivity with
uninfected Vero cell lysates (Fig. 3, lanes 5 and 6).
Aﬃnity-puriﬁed antibodies were then used to
localize NcMAG1 by IF and TEM. IF detection
of MAG1 in extracellular parasites showed that the
protein was distributed in a punctuated pattern
Fig. 1. The cDNA encoding NcMAG1. The largest cDNA clone (GenBank Accession no. EF580924, bottom) is
represented together with the deduced MAG1 precursor protein (GenBank Accession no. ABQ52425, top). The
predicted signal peptide cleavage site is indicated by a ﬁlled arrowhead. The 5k- and 3k-UTRs are in lowercase with the
two nucleotides diﬀering from the ApiDots DT.92484705 transcript underlined. Nucleotide residues at which
polyadenylation was observed in other cloned NcMAG1 cDNAs are shaded in grey. Sequences diﬀering at most by
1 nucleotide from the consensus polyadenylation signal (AATAAA) are boxed. Tandem repeat units (NT 1931–2016
and 2017–2107) present in the 3k-UTR are shown as horizontal arrows above the nucleotide sequence. Mismatches and
gaps created to align the two repeat units are displayed as ‘x’.
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within the cytoplasm.These punctuations weremore
apparent in bradyzoites (Fig. 4A). Staining of intra-
cellular tachyzoites detected the protein mostly
within the lumen of the parasitophorous vacuole
(PV); the PV periphery was also faintly labelled. In
contrast, after triggering tachyzoite-to-bradyzoite
conversion with SNP, a more pronounced staining
of the cyst wall and the cyst matrix was observed
(Fig. 4B and C). The eﬃciency of the in vitro stage
conversion using SNP treatment was conﬁrmed
using the bradyzoite-speciﬁc marker BAG1 on
Neospora-infected cells (Fig. 4B) and on puriﬁed
parasites (Fig. 4D). In a double-labelling experiment
with anti-recNcMAG1 and mAbCC2, a monoclonal
antibody directed against a cyst-speciﬁc antigen,
both antigens appeared to largely co-localize
(Fig. 4C)
By immunogold-TEM, performed on keratino-
cytes infected with N. caninum tachyzoites, minor
labelling was observed in the intra-parasitic space,
the lumen of the PV, and within the dense granule
organelles of the tachyzoites (Fig. 5A). Staining
of cell cultures undergoing SNP-treatment and
hence tachyzoite-to-bradyzoite stage conversion
(Fig. 5B–D) exhibited a much more pronounced
immunogold staining. Gold particles were abundant
within the cyst matrix and, in many cysts, also on the
cyst wall. In addition, dense granule (DG) organelles
were intensely labelled (Fig. 5B–D), indicating an
increased expression of NcMAG1 during stage
conversion, or an accumulation of the protein due to
reduced degradation.
Antibodies against the NcMAG1 conserved region,
but not the variable region, cross-react with
TgMAG1
Since NcMAG1 and TgMAG1 are orthologous
proteins, we investigated the potential antibody-
cross-reactivity of these antigens. Immunoblot and
immunoﬂuorescence using aﬃnity-puriﬁed anti-
bodies against the recombinantNcMAG1 resulted in
a weak, but distinct, cross-reactivity with T. gondii,
no matter whether cultures had been treated with
100 mM SNP or not (data not shown). We thus de-
termined, which region (conserved or variable) could
Fig. 2. Protein sequence alignment of deduced MAG1 precursors. Neospora caninum (Nc; GenBank Accession no.
ABQ52425, this work) and Toxoplasma gondii (Tg; GenBank Accession no. AAC46484) MAG1 predicted protein
sequences (single letter code) were aligned with MUSCLE and shaded according to the MM5 reduced, 5-letter amino
acid alphabet. Residue grouping is as follows: [C]; [FILMVWY]; [AG]; [H]; [DEKNPQRST]. Identical residues are
indicated by colons, similar residues are marked by dots. The putative signal peptide was identiﬁed with SignalP 3.0.
Boundaries between the predicted signal peptide, the conserved (C) C-terminal region (66% identity, aa 189–456) and
the less conserved (V) N-terminal region of NcMAG1 (32% identity, aa 31–188) are indicated by ﬁlled arrowheads.
Antibodies were raised against a large portion of a recombinant NcMAG1 (aa 31–394, not shown). Amino acid stretches
within the V and C regions, which were used for aﬃnity-puriﬁcation of antibodies speciﬁc to these regions are boxed.
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be responsible for this cross-reactivity.Western blots
were performed, using extracts of non-treated or
SNP-treated Neospora- and Toxoplasma-infected
cells. In order to enhance the detection of any
weak cross-reactivity, the samples loaded from
Toxoplasma-infected cells contained 5 times more
parasites than those loaded from Neospora-infected
cells (non-treated cells : 105 Neospora and 5r105
Toxoplasma ; SNP-treated cells : 104 Neospora and
5r104 Toxoplasma). Even though the Toxoplasma
samples were more concentrated in terms of parasite
numbers, the 65 kDa TgMAG1 was only faintly
detected by the antibodies aﬃnity-puriﬁed on the
conserved region of NcMAG1 in both non-treated
and SNP-treated cultures (Fig. 6A, upper panel,
lanes 3 and 7). In contrast, no cross-reactivity in
extracts containing Toxoplasma was observed when
antibodies aﬃnity-puriﬁed on the variable region
were used (Fig. 6A, lower panel, lanes 3 and 7). Note
that the 67 kDa NcMAG1 was recognized by both
aﬃnity-puriﬁed antibodies in Neospora-infected
cells (Fig. 6A, lanes 1 and 5). These results were
largely conﬁrmed by IF performed on infected cells
after treatment with SNP (Fig. 6B) or without
treatment (not shown). Antibodies directed against
the variable region of NcMAG1 failed to detect
T. gondii in spite of an exposure time 20 times longer
than what was used for the detection of Neospora.
DISCUSSION
The apicomplexan EST database (Li et al. 2003,
2004) allowed retrieval of the NcMAG1 sequence
and ampliﬁcation of the corresponding cDNA by
RACE. The 3k-ends of the NcMAG1 transcripts
were highly heterogeneous in size, strongly suggest-
ing that polyadenylation occurs at multiple sites.
Interestingly, a number of NcMAG1 mRNA pro-
perties were reminiscent of T. gondii dihydrofolate
reductase (DHFR) mRNA. Common features in-
clude the heterogeneity of the 3k-end lengths, the
absence of a consensus AATAAA polyadenylation
signal downstream of the coding sequence, and the
presence of a direct repeat in the 3k-UTR (Matrajt
et al. 2004). Half of the NcMAG1 transcripts
sequenced were polyadenylated within 10–30 NT
downstream of sequences diﬀering at most by 1 NT
from the consensus AATAAA hexamer. This sug-
gests that apicomplexan parasites, similarly to
mammals, may use, in addition to the consensus
AATAAA, some of its single NT sequence variants.
In the other half of the transcripts that we analysed,
there was no evident sequence reminiscent of a
consensus hexamer within 10–30 NT upstream of
the polyadenylation site, suggesting that, similar to
that observed in yeast, a variety of other positioning
elements might also be used (Guo and Sherman,
1995). In the DHFR transcript, the direct repeat in
the 3k-UTR was found to exert a slight stimulatory
eﬀect on chloramphenicol acetyltransferase (CAT)
expression in a CAT reporter assay (Matrajt et al.
2004). In this context, it would be of interest to assess
whether the 84/90 NT direct repeat present in
NcMAG1 3k-UTR would produce a similar eﬀect.
The deduced amino acid sequences of T. gondii
and N. caninumMAG1 share 54% identity and each
protein contains a single 30 aa hydrophobic domain,
which is located at the N-terminus and represents
a predicted signal peptide. Since TgMAG1 and
NcMAG1 do not exhibit any signiﬁcant similarity
with other proteins, it remains rather diﬃcult to
postulate a biological function for these proteins at
present. Given their relative abundance in the tissue
cysts ofT. gondii andN. caninum, they could possibly
exert a scaﬀolding role. In addition, the rather con-
servedC-terminal region ofMAG1 in the two closely
related parasites suggests that this part of the protein
could be involved in common functional activities.
To date, information concerning the composition
of N. caninum tissue cysts is limited, since they have
not been really amenable to experimental pro-
cedures. A protocol based on the SNP treatment
described by Vonlaufen et al. (2004) was used to
produceN. caninum tissue cysts in vitro. In this way,
Fig. 3. Western blot analysis of NcMAG1 expression in
Neospora caninum. Aﬃnity-puriﬁed antibodies raised
against a recombinant NcMAG1 were used to detect the
protein in lysates obtained from free parasites (Nc),
Neospora-infected Vero cells (Vero+Nc), and uninfected
Vero cells (Vero). Cultures were either left non-treated
(x) or treated for 9 days with SNP (+). Lanes 1 and 2:
lysates from 2r105 free N. caninum ; lanes 3 and 4: N.
caninum-infected Vero cells lysates containing 5r104
parasites. Total protein concentrations in control lanes 5
and 6 were adjusted to ﬁt those in lanes 3 and 4,
respectively. M: pre-stained protein marker; apparent
MWs in kDa are indicated. The open arrowhead
indicates the position of the 67 kDa NcMAG1 band.
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Fig. 4. Immunoﬂuorescence analysis of NcMAG1 expression. Neospora caninum were cultured in non-treated (xSNP)
or in SNP-treated Vero cells (+SNP), and analysed by indirect IF, either within infected host cells (B-C) or after
puriﬁcation from host cells (A and D). The primary antibodies were: anti-NcMAG1 aﬃnity-puriﬁed polyclonal
antibodies (MAG1), a polyclonal antibody directed against the bradyzoite-speciﬁc marker BAG1 (BAG1), the
monoclonal antibody CC2 directed against a cyst-speciﬁc antigen (CC2), and an antiserum directed against N. caninum
crude extract (Nc). The following secondary Alexa Fluor (AF)-labelled antibodies were used: AF-350 (blue), AF-488
(green) and AF-568 (red). An overlay image with DAPI staining of nuclei (B-C, blue) or with AF-350 staining of whole
parasites (A, blue) is presented on the right panel. Scale bars=5, 10 and 20 mm in panels (A), (B-C), and (D),
respectively.
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we could achieve up to 70% tachyzoite-to-bradyzoite
conversion, as demonstrated by staining with anti-
bodies directed against the bradyzoite-speciﬁc
BAG1 marker (McAllister et al. 1996). The high
percentage of stage conversion we achieved corro-
borates the validity of the comparison of NcMAG1
expression levels between tachyzoites and brady-
zoites.
Immunoblotting of lysates from puriﬁed parasites
of either tachyzoite or bradyzoite-converted cultures
showed a similar 67 kDa band reacting with anti-
NcMAG1 antibodies. This sharply contrasted
with the predicted MW of the mature NcMAG1
(50.5 kDa). A diﬀerence between the predicted and
the apparent MW of the protein was also observed in
TgMAG1 (Parmley et al. 1994). This diﬀerence
could, at least partially, be explained by post-
translational modiﬁcations such as extensive glyco-
sylations and/or phosphorylations. However, since
the recombinant NcMAG1 expressed in E. coli also
displayed an aberrant apparent MW in SDS-PAGE
(65 kDa instead of the predicted 41 kDa), it is very
likely that the main clue to the electrophoretic
mobility shift lies within the protein sequence itself.
The 67 kDa NcMAG1 product was more prominent
in puriﬁed bradyzoites than in tachyzoites, indicating
an increase in expression and/or a decrease of
the protein turnover (degradation) resulting in a net
Fig. 5. Immunolocalization of NcMAG1 by immunogold EM. TEM on Neospora caninum-infected mouse epidermal
keratinocytes using aﬃnity-puriﬁed anti-NcMAG1 primary antibodies. (A) Parasitophorous vacuole containing
tachyzoites. Note the relatively marginal staining of the tachyzoite dense granules (DG) and the vacuolar space between
the parasites. PVM, Parasitophorous vacuole membrane. (B–D) Cyst-like vacuoles obtained after SNP-treatment. Cysts
containing either a single parasite (B) or several parasites (C and D). Note the massive immunogold labelling within the
cyst matrix (CM), the dense granules (DG) and the cyst wall (CW). N depicts the nucleus, which remains virtually
unlabelled. Scale bars=0.25mm in (A) and (D) and 0.4mm in (B) and (C). Inserts in (A), (C) and (D) represent the
corresponding low-magniﬁcation views.
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accumulation of NcMAG1 in the developing cyst
matrix and wall.
The higher steady-state level of NcMAG1 in
bradyzoites was also conﬁrmed by IF analysis. Simi-
larly to TgMAG1 (Ferguson and Parmley, 2002),
NcMAG1 was highly abundant within tissue cysts.
The increase of NcMAG1 staining during stage
conversion was paralleled by that of BAG1within the
parasite cytoplasm. The staining obtained with mAb
CC2 and anti-NcMAG1 antibody also simul-
taneously increased during stage conversion, and
the two antigens appeared to largely co-localize. The
- SNP + SNP
+ SNP
Vero
+
Nc
Vero
+
Nc
Vero
+
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Vero
+
Tg
VeroVero Vero
+
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Vero
+
Nc
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+
Tg
VeroVero
1 2 3 4 5 6 7 8
α-NcMAG1-C
α-NcMAG1-V
nb. parasites 105 5×105 104 5×104
(A)
(B)
Fig. 6. Cross-reactivity of antibodies directed to the conserved or the variable region of NcMAG1. Polyclonal anti-
NcMAG1 antibodies were aﬃnity-puriﬁed on recombinant proteins corresponding to either the conserved (C) or the
variable (V) region of NcMAG1. The cross-reactivity of the resulting antibodies (a-NcMAG1-C and a-NcMAG1-V)
was assessed on Neospora caninum- (Vero+Nc) and Toxoplasma gondii-infected (Vero+Tg) Vero cells. (A) Western
blot analysis. Infected cell cultures were either left non-treated (xSNP) or treated with SNP to trigger tachyzoite to
bradyzoite conversion (+SNP). The number of parasites present in infected cell lysates is indicated. Total protein
concentrations in uninfected control extracts (Vero; even lanes), were adjusted to match those in the corresponding
infected cell extracts (odd lanes). The open and ﬁlled arrowheads indicate the positions of the 67 kDa NcMAG1 and the
65 kDa TgMAG1 bands, respectively. (B) Immunoﬂuorescence analysis. N. caninum or T. gondii were cultured in
SNP-treated Vero cells and analysed by indirect IF using a-NcMAG1-C or a-NcMAG1-V (green) and an antiserum
directed against either N. caninum (a-Nc) or T. gondii (a-Tg) crude extracts (red). Overlay images with DAPI staining
of nuclei (blue) are presented on the right. Green channel photographs were not enhanced post-acquisition; the
respective exposure times are indicated.
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antigen detected by mAb CC2 in cysts has not yet
been identiﬁed, but it is nevertheless unlikely that the
co-localization we observed was due to the binding of
mAbCC2 toMAG1. Indeed, mAb CC2 recognizes a
115 kDa glycosylated cyst antigen (Gross et al. 1995),
a MW, which does not ﬁt with the apparent MW
of neither NcMAG1 (y67 kDa) nor TgMAG1
(65 kDa) in bradyzoites. Therefore, NcMAG1 rep-
resents a reliable marker for the detection of
tachyzoite-to-bradyzoite stage conversion.
Immunogold TEM conﬁrmed the IF results and
revealed the presence of NcMAG1 within the cyst
wall and the cyst matrix, which was much more
pronounced compared to the labelling of the PV of
tachyzoite-infected cells. Importantly, the ultra-
structural study revealed that NcMAG1 was also
localized within DG. Taken together, our results
suggest that NcMAG1 is targeted to the DG and
subsequently released into the parasitophorous
vacuole in a process that is upregulated during
tachyzoite-bradyzoite stage conversion and cyst
formation.
The fact thatMAG1 is targeted to the cyst wall and
the cyst matrix following secretion from the DG
organelles was not surprising since the incorporation
of DG proteins into the cyst wall during cyst bio-
genesis has already been reported for other proteins
such as NcGRA1,NcGRA2 andNcGRA7, as well as
for the antigen recognized bymAbCC2, (Fuchs et al.
1998; Vonlaufen et al. 2002, 2004). With the ex-
ception of a few DG proteins, for which the function
is known (such as NTPases, cyclophilins and serine
protease inhibitors) the majority of these GRA pro-
teins, including T. gondii GRA1-10 and N. caninum
GRA1, 2, 3, 6, and 7, do not exhibit sequence simi-
larities with other known proteins (Adjogble et al.
2004; Ahn et al. 2005; Mercier et al. 2005).
Moreover, their function remains largely unknown,
except for TgGRA7, which participates in seques-
tering host cell lysosomes into the vacuolar space by
acting like a garrote. However, this process does
apparently not occur in N. caninum (Coppens et al.
2006).
GRA proteins share a few common features, in-
cluding a signal peptide that appears to be suﬃcient
to target the proteins to DG organelles and, being
ubiquitous (Mercier et al. 2005) was predicted in the
NcMAG1 primary sequence. An additional charac-
teristic of GRA proteins that was also observed in
MAG1 is the intriguing diﬀerence between the MW
predicted from the protein primary sequence and the
higher MW observed on SDS-PAGE gels (Mercier
et al. 2005). A trans-membrane domain present in
most (TgGRA3-10), but not all GRA proteins (Ahn
et al. 2005; Mercier et al. 2005) was, however, not
found in NcMAG1.
Interestingly, even though MAG1 is more abun-
dant in bradyzoites and accumulates into cysts that
deﬁne the chronic stage of infection, it was described
as an antigen detected promptly after infection with
T. gondii. Di Cristina et al. (2004) showed that a
fragment of MAG1 (aa 28–126, therefore within the
region we refer to as ‘variable’) is highly im-
munogenic and triggers a B-cell response in 73% of
healthy individuals. The immune response against
MAG1 is rapid, appearing as early as 1 month after
infection (Di Cristina et al. 2004). Recombinant
TgMAG1 was also tested, with encouraging results,
in order to improve current serodiagnostic methods
of acute toxoplasmosis during pregnancy (Pfrepper
et al. 2005; Holec et al. 2007).
Two studies have so far reported that an eﬃcient,
although partial, protection against challenge with
T. gondii cysts could be obtained, as evidenced by a
marked reduction in the number of cerebral cysts
following immunization with TgMAG1 alone
(Parmley et al. 2002) or combined with a bradyzoite-
speciﬁc antigen (Nielsen et al. 2006). In the ﬁrst
study, Parmley et al. demonstrated that vaccination
with the 79-aa C-terminal part of TgMAG1 signiﬁ-
cantly increased the survival rate of animals and re-
duced the number of cerebral cysts by as much as
about 3-fold. In the second study, Nielsen et al. ob-
served an eﬀective protection after DNA vaccination
with a mixture of 2 plasmid vectors encoding
TgMAG1 and the bradyzoite-speciﬁc TgBAG1.
A preferential induction of antibodies of the IgG2a
subclass directed against the immunizing antigens
was also observed (Nielsen et al. 2006). Altogether,
these results indicate that MAG1 could be a useful
antigen for diagnosis, as well as a promising candi-
date for vaccination trials in T. gondii.
Recently, the use of NcMAG1 as a vaccine
was assessed in an acute disease mouse model for
neosporosis (Debache et al. 2009). In this exper-
iment, mice were vaccinated either intraperitoneally
or intranasally and, following challenge infection
with N. caninum tachyzoites, a partial (50%) protec-
tion was observed for the intraperitoneally vacci-
nated animals, while only 10% of animals survived
the challenge following intranasal vaccination.
However, application of NcMAG1 as a vaccine will
make more sense in the context of re-activation of
neosporosis in chronically infected animals har-
bouring tissue cysts, or the challenge should ideally
be performed by oral administration of tissue cysts.
This procedure appeared to be diﬃcult to carry out
since, at present, only a limited number of studies
have demonstrated the possibility to produce
N. caninum cysts in immunosuppressed mice
(McGuire et al. 1997; Rettigner et al. 2004). Thus, a
more suitable experimental model than the mouse,
such animals possessing the ability to develop
cerebral tissue cysts, should preferentially be used.
Even though the MAG1 primary sequences in
T. gondii andN. caninum share a high degree (66%) of
identity at their C-termini, only limited, but still
clear, antibody cross-reactivity was observed in
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Toxoplasmawhen anti-NcMAG1 antibodies aﬃnity-
puriﬁed on the relatively conserved C-terminal re-
gionwere tested.No cross-reactivity was foundwhen
antibodies aﬃnity-puriﬁed on the variable region
were assessed. Both aﬃnity-puriﬁed antibodies re-
acted with N. caninum tachyzoites and bradyzoites.
This indicates that only the variable but not the
conserved region of the protein could be an ideal tool
for distinguishing betweenToxoplasma andNeospora
species, and corresponding investigations are cur-
rently being carried out to investigate the sero-
diagnostic potential of the NcMAG1 variable region.
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